PRESS RELEASES

April 4th, 2011

Lithera, Inc. Appoints Thomas Wiggans to Board of Directors

March 21st, 2011

Lithera Announces the Appointment of George W. Mahaffey as President and Chief Executive Officer

November 3rd, 2010

Lithera Reports Positive Clinical Study Results from a Phase IIb Trial for LIPO-102, a Novel Treatment for Localized Fat Reduction

October 12th, 2010

Lithera Announces Notice of Allowance for a Key Patent Application for LIPO-102, a Novel Treatment for Localized Fat Reduction

May 13, 2010

Lithera's Phase II Fat Reduction Drug Aims to Follow Botox Model

May 05, 2010

Lithera Reports Positive Clinical Study Results from a Second Phase IIa Trial for LIPO-102, a Novel Treatment for Localized Fat Reduction

March 09, 2010

Lithera Reports Positive Phase IIa Clinical Study Results for LIPO-102, a Novel Treatment for Localized Fat Reduction

February 23, 2010

Lithera Obtains Orphan Drug Product Designation for LIPO-102

February 9, 2010

Lithera Successfully Completes Phase I Clinical Trial of LIPO-102

EVENTS

October 5, 2010

Lithera to Present at Three Upcoming Conferences